FDA grants AstraZeneca-Merck’s selumetinib breakthrough therapy designation
AstraZeneca has announced the US...
Read MoreAstraZeneca has announced the US...
Read MoreFresh from having gained the...
Read MoreSeattle Genetics, Inc. (Nasdaq:SGEN) today...
Read MoreNovartis on Monday announced it...
Read MoreIn a path breaking initiative...
Read MoreDrug maker Zydus Cadila Friday...
Read MoreBayer will present research from...
Read MoreDiA Imaging Analysis, a leading...
Read MoreRegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)...
Read More